Clinical Trial Update: Evaluation of Prototype Lenses With Experimental UV/HEV Blocker [NA]

View source ↗

Summary

A completed clinical trial evaluating prototype lenses with an experimental UV/HEV blocker, focusing on visual acuity outcomes; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Visual Acuity Disorders

Drugs mentioned

• Prototype lenses with UV/HEV blocker

Snippet

Sponsor: Johnson & Johnson Vision Care, Inc. | Conditions: Visual Acuity | NA | Status: COMPLETED | Results posted: 2022-09-01